• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.69% Nasdaq Up 0.44%

    Opexa Therapeutics, Inc. (OPXA)

    -NasdaqCM
    0.41 Down 0.01(2.41%) Jul 29, 3:59PM EDT
    Add to Portfolio
    Prev Close:0.42
    Open:0.42
    Bid:0.40 x 5000
    Ask:0.51 x 2000
    1y Target Est:5.00
    Beta:2.68
    Earnings Date:Aug 12 - Aug 17 (Est.)
    Day's Range:0.41 - 0.43
    52wk Range:0.33 - 1.59
    Volume:238,789
    Avg Vol (3m):1,568,280
    Market Cap:21.62M
    P/E (ttm):N/A
    EPS (ttm):-0.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OPXA

    Comparison

    Symbol% ChgMkt Cap
    OPXADown 2.41%21.62M
    SNYDown 2.17%137.65B
    TEVADown 0.74%60.11B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):17.03
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.36
    Quarterly EPS Est (Jun-15) :-0.08
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases, such as neuromyelitis optica (NMO) based on its proprietary T-cell technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback